You are here: Industry Insights > MD Anderson

News List

Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies prnasia
July 12, 2021
Hummingbird Bioscience and The University of Texas MD Anderson Cancer Center today announced the launch of a multi-year strategic research collaboration to investigate and evaluate HMBD-002, Hummingbird's VISTA antagonist antibody.
Xencor, MD Anderson enter collaboration to develop novel T cell-engaging bispecific antibodies for potential treatment of cancer pharmaceutical-business-review
January 13, 2021
Xencor and The University of Texas MD Anderson Cancer Center announced a strategic research collaboration and commercialization agreement to develop novel CD3 bispecific antibody therapeutics for the potential treatment of patients with cancer.
Rakuten Medical, MD Anderson Announce Collaboration to Advance Illuminox Platform americanpharmaceuticalreview
June 16, 2020
Rakuten Medical and The University of Texas MD Anderson Cancer Center (MD Anderson) announced a strategic alliance collaboration agreement to advance the development of new cancer therapies based on Rakuten Medical's proprietary Illuminox™ technology ...
Boehringer partners with MD Anderson on virtual R&D centre pharmaceutical-technology
August 15, 2019
Boehringer Ingelheim has collaborated with The University of Texas MD Anderson Cancer Center to create a joint Virtual Research and Development Center focused on oncology research.
Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alliance in Cancer Drug Development pharmafocusasia
January 09, 2019
Ascentage Pharma Group, Inc., and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.....
Inflection Biosciences Announces Research Collaboration with MD Anderson pharmafocusasia
November 05, 2018
Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced that it has entered into a research...
MD Anderson, Accelerator bake up Magnolia, an NYC biotech in neuroprotection, with $31M series A fiercebiotech
August 14, 2018
MD Anderson Cancer Center and Accelerator Life Science Partners have co-founded a new company, Magnolia Neurosciences, to develop a new class of targeted neuroprotective drugs discovered by the cancer center’s researchers.